AMC Health, a New York-based telehealth company, has named Michael O'Brien as president of its clinical trials division.
O'Brien, 52, was the president and CEO of Beardsworth Consulting Group, a contract-research group headquartered in Flemington, N.J. The move is a sign of the company's expansion into new areas within healthcare.
“We are excited to have an industry veteran like Michael O'Brien leading this charge for our company," said AMC President and CEO Nesim Bildirici in a news release. “Pharmaceutical companies have faced real challenges enrolling and retaining participants for clinical trials, collecting accurate data and analyzing and reporting the results. Innovative telemonitoring technology in clinical trials will transform drug development in an industry that is poised to take advantage of its many benefits.”
O'Brien has 30 years of C-Suite-related experiences with the life sciences and information technology industries.
Follow Ashok Selvam on Twitter: @MH_aselvam
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
